ARTICLE | Politics, Policy & Law
Lawmakers vigilant in watching for COVID-19-related price gouging
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
May 5, 2020 2:07 AM UTC
Updated on May 5, 2020 at 5:20 PM UTC
A letter from a House of Representatives committee expressing concern over a price hike for a drug that could be used in COVID-19 patients underscores Congress’ readiness to call out what it perceives to be unfair pricing practices during the pandemic.
Committee on Oversight and Reform Chair Carolyn Maloney (D-N.Y.) and committee member Rep. Jackie Speier (D-Calif.) sent a letter to Jaguar Health Inc. (NASDAQ:JAGX) urging the company to reverse a price increase on Mytesi crofelemer...